Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-698-9 | CAS number: 17696-62-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- publication
- Title:
- Assessment of the sensitizing potency of preservatives with chance of skin contact by the loose-fit coculture-based sensitisation assay (LSCA)
- Author:
- Sonnenburg A. et al.
- Year:
- 2 015
- Bibliographic source:
- Arch Toxicol 89, 2339-2344
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- In the publication the results after conducting the loose-fit coculture-based sensitisation assay (LSCA) were provided. The coculture of primary human keratinocytes and allogenic dendritic cell-related cells (DC-rc) were used to emulate the in vivo situation of human skin.
- GLP compliance:
- not specified
- Remarks:
- Study is published and it is not further specified, if the GLP did apply
- Type of study:
- activation of dendritic cells
Test material
- Reference substance name:
- Phenyl 4-hydroxybenzoate
- EC Number:
- 241-698-9
- EC Name:
- Phenyl 4-hydroxybenzoate
- Cas Number:
- 17696-62-7
- Molecular formula:
- C13H10O3
- IUPAC Name:
- phenyl 4-hydroxybenzoate
Constituent 1
- Specific details on test material used for the study:
- - Source: TCI Deutschland GmbH, Eschborn, Germany
In vitro test system
- Details on the study design:
- Skin sensitisation (In vitro test system) - Details on study design:
Keratinocytes were isolated from skin which was received as residual material from plastic surgery. PBMCs were enriched from buffy coats by density centrifugation. Cells were cocultured in serum-free KGM-2 (PromoCell, Heidelberg, Germany) on 12-well cell culture plates. Increasing concentrations of test substances were tested until significant cytotoxicity or decreased solubility occurred. Viability of cells was measured by 7-AAD staining. Each substance was tested with three different DC-rc/KC-donor pairs to account for interindividual variability. TNBS at a concentration of 100 µmol/L served as positive control.
FACS ANALYSIS:
FACS analysis was performed on a FACS Calibur flow cytometer (BD Biosciences). Cells were gated to a distinct population of DC-rc according to their scatter properties. Of three cell populations to be seen in a scatter dot plot, one is CD14+, one CD4+CD8+ and one CD86+. The latter is considered to be the DC-rc population and is therefore gated. The experiments were assumed to be reliable, when the addition of TNBS led to an at least 1.4-fold increase in CD86 expression compared to zero controls. Relative upregulation of CD86-expression was calculated by the following equation: MFI (CD86 of treated cells)/MFI (CD86 of vehicle control). 7-AAD staining was used to determine and exclude dead cells from the calculation. Dose-effect relationships for relative CD86-expression and viability as well as EC50 values were determined using GraphPadPrism software.
Categorisation:
For categorisation of sensitising potency, the substance concentration which led to a half-maximal increase in CD86-expression (EC50 sens) was assessed. Substances were categorized as follows: half-maximal increase in CD86-expression <12.5 µM: extreme; <50 µM: strong; <100 µM: moderate and >100 µM: weak. Substances failing to elicit significant rise in CD86-expression up to the maximum test concentration were deemed non-sensitisers.
Likewise, categorisation of irritative potency is based on the concentration that resulted in cell death of 50% (EC50vit) of DC-rc as compared to vehicle controls. Substances eliciting 50% cell death at concentrations below 50 µM were considered to be irritative. Those with an EC50vit value from 50 to 1000 µM were considered to be weakly irritative. Substances that did not reach the 50% threshold or with EC50(vit) values above 1000 µM were rated as non-irritative.
Results and discussion
In vitro / in chemico
Results
- Key result
- Run / experiment:
- other: mean of triplicates
- Parameter:
- other: EC50sens (µmol/L)
- Value:
- 69.23
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
- Other effects / acceptance of results:
- Based on a EC50sens value of 69.23 µmol/L the test substance can be considered as moderate skin sensitising. The EC50vit was 416.17 µmol/L, indicating that the substance is weakly irritative.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- Based on the results from an in vitro skin sensitisation assay, namely the loose-fit coculture-based sensitisation assay (LCSA), the test item phenylparaben must be considered as moderate skin-sensitiser.
- Executive summary:
In a loose-fit coculture-based sensitisation assay (LCSA), keratinocytes were isolated from skin which was received as residual material from plastic surgery. PBMCs were enriched from buffy coats by density centrifugation. Cells were cocultured in serum-free KGM-2 (PromoCell, Heidelberg, Germany) on 12-well cell culture plates. Each substance was tested with three different DC-rc/KC-donor pairs to account for interindividual variability. TNBS at a concentration of 100 µmol/L served as positive control. Dose-effect relationships for relative CD86-expression and viability as well as EC50 values were determined using GraphPadPrism software. Based on a EC50sens value of 69.23 µmol/L, can the test substance be considered as moderate skin sensitising. The EC50vit was 416.17 µmol/L, indicating that the substance is weakly irritative.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.